Patents by Inventor Jean-François Peyronel

Jean-François Peyronel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8691990
    Abstract: Compounds of formula (I): in which: X, R1, R2, R3 and R4 are as defined in the disclosure, or an acid addition salt thereof; and therapeutic use thereof.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: April 8, 2014
    Assignee: Sanofi
    Inventor: Jean-Francois Peyronel
  • Patent number: 8404848
    Abstract: The present invention is related to a compound of formula (I): wherein R1, R2, R3, R4 and X are as defined herein, or an addition salt with an acid thereof, its pharmaceutical composition or use for treating or preventing diseases involving Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: March 26, 2013
    Assignee: Sanofi
    Inventors: Youssed El-Ahmad, Anne Olivier, Jean-Francois Peyronel
  • Publication number: 20130041152
    Abstract: Compounds of formula (I): in which: X, R1, R2, R3 and R4 are as defined in the disclosure, or an acid addition salt thereof; and therapeutic use thereof.
    Type: Application
    Filed: October 10, 2012
    Publication date: February 14, 2013
    Inventor: Jean-Francois PEYRONEL
  • Patent number: 8314109
    Abstract: Compounds of formula (I): in which: X, R1, R2, R3 and R4 are as defined in the disclosure, or an acid addition salt thereof; and therapeutic use thereof.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: November 20, 2012
    Assignee: Sanofi
    Inventor: Jean-Francois Peyronel
  • Patent number: 7902219
    Abstract: The present invention is related to a compound of formula (I) wherein R1, R2, R3, R4 and X are as defined herein, or an acid-addition salt thereof, its preparation and therapeutic use in the treatment or prevention of diseases involving the Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: March 8, 2011
    Assignee: Sanofi-Aventis
    Inventors: Jean-Francois Peyronel, Youssef El-Ahmad
  • Publication number: 20100317675
    Abstract: Compounds of formula (I): in which: X, R1, R2, R3 and R4 are as defined in the disclosure, or an acid addition salt thereof; and therapeutic use thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: sanofi-aventis
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20100317620
    Abstract: Compounds of formula (I): in which X, R1, R2, R3, and R4 are as defined in the disclosure, or an acid addition salt thereof; and therapeutic uses thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: sanofi-aventis
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20100317685
    Abstract: Compounds of formula (I): wherein: X, R1, R2, R3, and R4 are as defined in the disclosure, and therapeutic uses thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: SANOFI-AVENTIS
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20100317673
    Abstract: Compounds of formula (I): in which: X, R1, R2, R3, and R4 are as defined in the disclosure, in the form of the base or of an addition salt with an acid; and therapeutic uses thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: SANOFI-AVENTIS
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20100317686
    Abstract: Compounds of formula (I): in which: X, R1, R2, R3 and R4 are as defined in the disclosure, or an acid addition salt thereof; and therapeutic use thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: sanofi-aventis
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20100317688
    Abstract: Compounds of formula (I): in which: X, R1, R2, R3, and R4 are as defined in the disclosure, or an acid addition salt thereof; an therapeutic use thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: SANOFI-AVENTIS
    Inventor: Jean-Francois Peyronel
  • Publication number: 20100317687
    Abstract: Compounds of formula (I) in which: X, R1, R2, R3, and R4 are as defined in the disclosure, or an acid addition salt thereof; and therapeutic use thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: sanofi-aventis
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20100317656
    Abstract: Compounds of Formula (I): wherein X, Y, R1, R2, R3, and R4 are as defined in the disclosure, or a acid addition salt thereof; and therapeutic use thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 16, 2010
    Applicant: SANOFI-AVENTIS
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20100168155
    Abstract: The present invention is related to a compound of formula (I): wherein R1, R2, R3, R4 and X are as defined herein, or an addition salt with an acid thereof, its pharmaceutical composition or use for treating or preventing diseases involving Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
    Type: Application
    Filed: February 24, 2010
    Publication date: July 1, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Youssed EL-AHMAD, Anne OLIVIER, Jean-Francois PEYRONEL
  • Patent number: 7704989
    Abstract: The present invention is related to a compound of formula (I): wherein R1, R2, R3, R4 and X are as defined herein, or an addition salt with an acid thereof, its pharmaceutical composition or use for treating or preventing diseases involving Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: April 27, 2010
    Assignee: Sanofi-Aventis
    Inventors: Youssef El-Ahmad, Anne Olivier, Jean-Francois Peyronel
  • Publication number: 20090149494
    Abstract: The present invention is related to the use of a compound of formula (I): Wherein R1, R2, R3, R4 and X are as defined herein, or an addition salt with an acid, for the preparation of a medicament for treating or preventing diseases in which the NOT receptor is involved.
    Type: Application
    Filed: December 17, 2008
    Publication date: June 11, 2009
    Applicant: SANOFI-AVENTIS
    Inventor: Jean-Francois PEYRONEL
  • Publication number: 20090149441
    Abstract: The present invention is related to a compound of formula (I): wherein R1, R2, R3, R4 and X are as defined herein, or an addition salt with an acid thereof, its pharmaceutical composition or use for treating or preventing diseases involving Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
    Type: Application
    Filed: December 17, 2008
    Publication date: June 11, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Youssed EL-AHMAD, Anne OLIVIER, Jean-Francois PEYRONEL
  • Publication number: 20090143420
    Abstract: The present invention is related to a compound of formula (I) wherein R1, R2, R3, R4 and X are as defined herein, or an acid-addition salt thereof, its preparation and therapeutic use in the treatment or prevention of diseases involving the Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
    Type: Application
    Filed: December 17, 2008
    Publication date: June 4, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Jean-Francois PEYRONEL, Youssef EL-AHMAD
  • Publication number: 20090143421
    Abstract: The present invention is related to the use of a compound of formula (I): wherein R1, R2, R3, R4 and X are as defined herein, or an addition salt with an acid, for treating or preventing illnesses involving the nuclear receptors Nurr-1, also known as NR4A2, NOT, TINUR, RNR-1, and HZF3.
    Type: Application
    Filed: December 17, 2008
    Publication date: June 4, 2009
    Applicant: SANOFI-AVENTIS
    Inventor: Jean-Francois PEYRONEL
  • Patent number: 6713468
    Abstract: Methods of using compounds of formula (I): their racemates, enantiomers, diastereoisomers and inorganic acid salts and organic acid salts thereof.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: March 30, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Claude Hardy, Jean Bouquerel, Patrick Nemecek, Jean-Claude Aloup, Serge Mignani, Jean-François Peyronel